274 results on '"Katzenellenbogen, Benita S."'
Search Results
2. NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells
3. Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs
4. Endothelial ERα promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle
5. Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
6. Somatic estrogen receptor [alpha] mutations that induce dimerization promote receptor activity and breast cancer proliferation
7. FOXM1 regulates glycolysis and energy production in multiple myeloma
8. Dual-mechanism estrogen receptor inhibitors
9. Iterative Catalyst-Controlled Diastereoselective Matteson Homologations Enable the Selective Synthesis of Benzestrol Isomers.
10. Asymmetric Allostery in Estrogen Receptor-α Homodimers Drives Responses to the Ensemble of Estrogens in the Hormonal Milieu
11. Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression
12. The tissue-specific effects of different 17β-estradiol doses reveal the key sensitizing role of AF1 domain in ERα activity
13. Abstract B010: Development of folate receptor alpha targeted FOXM1 inhibitors for ovarian cancer
14. Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ERα-negative tumor growth
15. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer
16. Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors
17. Asymmetric allostery in estrogen receptor-a homodimers drives responses to the ensemble of estrogens in the hormonal milieu.
18. OR11-01 A New Model for Estrogen Receptor-alpha Antagonist Mechanism of Action
19. Non-nuclear estrogen receptor alpha activation in endothelium reduces cardiac ischemia-reperfusion injury in mice
20. Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity
21. Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance
22. Abstract 3984: NB compound FOXM1 inhibitors have potent anti-cancer activity in high-grade serous ovarian carcinoma
23. Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
24. Supplementary Table from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
25. Data from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
26. Estrogen receptor-α and aryl hydrocarbon receptor involvement in the actions of botanical estrogens in target cells
27. Endocrine treatment in breast cancer: Cure, resistance and beyond
28. Differential utilization of nuclear and extranuclear receptor signaling pathways in the actions of estrogens, SERMs, and a tissue-selective estrogen complex (TSEC)
29. The anticancer potential of steroidal saponin, dioscin, isolated from wild yam (Dioscorea villosa) root extract in invasive human breast cancer cell line MDA-MB-231 in vitro
30. Licorice root components in dietary supplements are selective estrogen receptor modulators with a spectrum of estrogenic and anti-estrogenic activities
31. Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
32. Data from Structurally Novel Antiestrogens Elicit Differential Responses from Constitutively Active Mutant Estrogen Receptors in Breast Cancer Cells and Tumors
33. Supplementary Figures_S1-S6 from Structurally Novel Antiestrogens Elicit Differential Responses from Constitutively Active Mutant Estrogen Receptors in Breast Cancer Cells and Tumors
34. Supplementary Tables 1-3 from Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells and Correlations with Clinical Outcome
35. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer
36. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression
37. Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancet cells
38. Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer
39. Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling
40. Erratum To: Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
41. Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
42. New 1,1-diarylethylene FOXM1 inhibitors potently reduce intracellular FOXM1 and suppress high-grade serous ovarian carcinoma cell viability
43. Dietary licorice root supplementation reduces diet-induced weight gain, lipid deposition, and hepatic steatosis in ovariectomized mice without stimulating reproductive tissues and mammary gland
44. Multiple Beneficial Roles of Repressor of Estrogen Receptor Activity (REA) in Suppressing the Progression of Endometriosis
45. Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer
46. Abstract P205: Novel 1,1-diarylethylene compounds degrade FOXM1 and selectively and potently reduce survival of high-grade serous ovarian cancer cells
47. Publisher Correction: Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance
48. Protective Hematopoietic Effect of Estrogens in a Mouse Model of Thrombosis: Respective Roles of Nuclear Versus Membrane Estrogen Receptor α
49. Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
50. Targeting metabolic adaptations in the breast cancer–liver metastatic niche using dietary approaches to improve endocrine therapy efficacy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.